NOVAVAX, INC. (NVAX) Revenue 2016–2025
NOVAVAX, INC. (NVAX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.1BFY2025 · since FY2016: $15.4M → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | +64.7% |
| FY2024 | $682.2M | -30.7% |
| FY2023 | $983.7M | -50.4% |
| FY2022 | $2.0B | +72.9% |
| FY2021 | $1.1B | +141.0% |
| FY2020 | $475.6M | +2448.5% |
| FY2019 | $18.7M | -45.6% |
| FY2018 | $34.3M | +10.0% |
| FY2017 | $31.2M | +103.1% |
| FY2016 | $15.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice